Skip to content
Review Open access

Cancer genomic data systems in precision oncology: from integration to clinical implementation

Sep 2026 · EBioMedicine · Vol 132, pp. 106480 · 1 citation · 36 references
Medicine

TL;DR

Without robust data stewardship, including effective data sharing and global integration, the potential of cancer genomics will remain fragmented across projects, platforms, and jurisdictions, and this disaggregation limits reproducibility, equity, patient benefit, and societal value.

Abstract

Summary Cancer genomic data sharing is a core pillar of precision oncology, underpinning reproducibility, scalability, and equity. The ability to discover, access, integrate, interpret, and reuse cancer ‘omics data is a key determinant of precision oncology's value and benefit at scale. This work has been conducted as part of The Lancet Oncology Commission on Cancer Genomics and Precision Oncology to examine the practical data architecture required to support cancer genomics in research, clinical care, and health-system learning. We conclude that without robust data stewardship, including effective data sharing and global integration, the potential of cancer genomics will remain fragmented across projects, platforms, and jurisdictions. This disaggregation limits reproducibility, equity, patient benefit, and societal value. Healthcare systems must prioritise implementing fully efficient data ecosystems as a central challenge for precision oncology.

Read PDF

Similar papers

Review Open access Sep 2026

Accelerating equitable cancer genomics and precision oncology in health care and research: a Lancet Oncology Commission.

The Commission developed a value-based resource-stratified implementation framework, a system-readiness assessment tool, a precision oncology workforce competency-based framework, a precision oncology monitoring and evaluation framework, and principles for responsible data sharing and health-system learning.

R. Casolino, J. Mateo, E. D. de Vries et al. · 11 citations
Review Open access Sep 2026

From free text to structured genomics: future-proofing cancer registries for precision oncology

Molecular pathology has become central to precision oncology, but German cancer registry data structures were designed for simpler molecular findings. This study argues that registries need a minimal, structured, and interoperable representation of molecular variants that remains compatible with data minimization and e...

J. Zohner, C. Kuhl, K. Schmid et al. · 0 citations
Review Open access Nov 2026

State of Precision Oncology: An Australian Perspective

Precision oncology is redefining cancer therapeutics worldwide. In Australia, the integration of genomic medicine into routine clinical oncology remains inconsistently constrained by fragmented funding mechanisms, regional disparities, and a limited workforce. Understanding these structural and policy challenges is cru...

Samrin Liaqat, M. Khattak · 0 citations
Review Open access Nov 2026

Toward Equitable Precision Oncology: Real-World Validation of an AI-Powered Trial Matching Platform

Limited oncology workforce capacity, fragmented electronic health records (EHRs), and labor-intensive chart abstraction contribute substantially to under-enrollment in cancer clinical trials worldwide, particularly in resource-constrained settings. We evaluated a GPT-4o–based artificial intelligence platform design...

Yan Leyfman, A. Loaiza-Bonilla, E. Tuysuz et al. · 0 citations
Review Open access 2026

Development of biobanks for precision medicine in breast cancer: a platform for molecular and immunological biomarker research

Biobanks constitute foundational infrastructure for precision breast oncology, bridging discovery science and clinical implementation, and their capacity to integrate multi-omics datasets with functional tumor models positions them as essential drivers of individualized therapy.

Gabriela Schneider, Betina Vollbrecht · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.